Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-794-1 | CAS number: 126-58-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute oral LD50 of the substance in the rat is >2000 mg/kg bw. The acute 4-hour inhalation LC50 of the substance in the rat is >5.07 mg/L. No data is available for acute dermal toxicity, however very low toxicity can be predicted.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04.09.1991 to 13.01.1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): dipentaerythritol
- Substance type: white powder
- Physical state: solid
- Analytical purity: 96.2%
- Purity test date: received 2-sept-1991
- Lot/batch No.: 9404
- Expiration date of the lot/batch: 2-11-1992
- Storage condition of test material: room temperature in the dark - Species:
- rat
- Strain:
- other: Sprague-Dawley origin Crl.CD(SD)BR VAF plus
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River U.K. Limited, Margate, Kent, England
- Age at study initiation: four to seven weeks
- Weight at study initiation: 116-134 g
- Fasting period before study: overnight and 4 hours after dosing
- Housing:The rats were allocated without conscious bias to cages within the treatment group. They were housed in groups of up to five rats of the same sex in metal cages with wire mesh floors in Building R14 Room 6.
- Diet (e.g. ad libitum): A standard laboratory rodent diet (Biosure LAD 1) were provided ad libitum
- Water: ad libitum
- Acclimation period:7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 23°C
- Humidity (%): 60%
- Air changes (per hr): 10 to 15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 04 September 1991 To: 18 September 1991. - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 20% w/v in distilled water
MAXIMUM DOSE VOLUME APPLIED: 10 ml/kg bw - Doses:
- 2.0g/kg bw
- No. of animals per sex per dose:
- 5 rats/sex/dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observed for clinical signs daily; bodyweights recorded on day 1, day 8, and day 15
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- Statistics were not performed
- Preliminary study:
- No preliminary study was reported.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No deaths at the limit dose
- Mortality:
- There were no deaths following a single oral dose of dipentaerythritol at 2.0 g/kg bodyweight.
- Clinical signs:
- other: Piloerection and abnormal body carriage (hunched posture) were observed in all rats within five minutes of dosing and throughout the remainder of Day 1. There were no other clinical signs and recovery, as judged by external appearance and behaviour, was
- Gross pathology:
- No macroscopic abnormalties were observed for animals killed on Day 15.
- Other findings:
- No other findings reported.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The substance is of low acute toxicity.The acute oral LD50 of dipentaerythritol to rats was > 2000 mg/kg bw under the conditions of this study. Classification is not required.
- Executive summary:
A study was performed to assess the acute oral toxicity of dipentaerythritol to the rat. The method followed was that described in EEC Methods for the determination of toxicity, Directive 84/449/EEC (OJ No. L251, 19.9.84), Part B, Method B.1. Acute toxicity (oral).
A group of ten fasted rats (five males and five females) was given a single dose by gavage of the test substance, formulated in distilled water, at a dose level of 2.0 g/kg bodyweight. All animals were killed and examined macroscopically on Day 15, the end of the observation period.
There were no deaths. Clinical signs of reaction to treatment were limited to piloerection and abnormal body carriage and recovery was complete by Day 2. Slightly low bodyweight gains were recorded for three males on Day 8; these rats achieved anticipated gains on Day 15. All other rats achieved anticipated bodyweight gains throughout the study. No abnormalities were recorded at the macroscopic examination on Day 15.
The acute lethal oral dose to rats of dipentaerythritol was found to be greater than 2.0 g/kg bodyweight under the conditions of this study. Dipentaerythritol is not classified for acute oral toxicity according to the CLP Regulation.
Reference
No additional information.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- > 2 000 mg/kg bw
- Quality of whole database:
- A guideline and GLP-compliant rat study is available for this endpoint
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2015-10-13 to 2015-11-05
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Version / remarks:
- 2009
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.2 (Acute Toxicity (Inhalation))
- Version / remarks:
- 2014
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Envigo RMS (UK) Limited, Oxon, UK.
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 200-350 g
- Housing: groups of up to five by sex in solid-floor polypropylene cages with stainless steel lids, furnished with softwood flakes (Datesand Ltd., Cheshire, UK) and provided with environmental enrichment items: wooden chew blocks and cardboard “fun tunnels” (Datesand Ltd., Cheshire, UK).
- Diet (e.g. ad libitum): Rodent 2014C Teklad Global Certified Diet (Envigo RMS (UK) Limited, Oxon, UK), ad libitum
- Water (e.g. ad libitum): mains drinking water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25°C
- Humidity (%): 30-70%
- Air changes (per hr): at least 15/hour
- Photoperiod (hrs dark / hrs light): 12 hour cycle
IN-LIFE DATES: From: 13 October 2015 To: 05 November 2015 - Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- nose only
- Vehicle:
- air
- Mass median aerodynamic diameter (MMAD):
- 1.73 µm
- Geometric standard deviation (GSD):
- 3.5
- Details on inhalation exposure:
- In order to facilitate aerosolisation and reduce particle size, the test item was ground using a Retsch Planetary Ball Mill (Retsch (UK) Ltd, Leeds, UK) prior to use. A dust atmosphere was produced from the test substance using a SAG 410 Solid Aerosol Generator (TOPAS GmbH, Dresden, Germany) located adjacent to the exposure chamber. The SAG 410 was connected to a metered compressed air supply. Compressed air was supplied by means of an oil free compressor and passed through a water trap and respiratory quality filters before it was introduced to the SAG 410. The cylindrical exposure chamber had a volume of approximately 30 liters (dimensions: 28 cm diameter x 50 cm high). The concentration within the chamber was controlled by adjusting the test substance feed rate from the SAG 410. The extract from the exposure chamber passed through a ‘scrubber’ trap and was connected with a high efficiency filter to a metered exhaust system. The chamber was maintained under negative pressure.
One day prior to the day of exposure, each rat was acclimatized (for approximately 2 hours) to a tapered polycarbonate restraining tube. During the exposure period, each rat was individually held in a tapered, polycarbonate restraining tube fitted onto a single tier of the exposure chamber
and sealed by means of a rubber ‘O’ ring. Only the nose of each animal was exposed to the test atmosphere. Following an appropriate equilibration period a single group of ten rats (five males and five females) was exposed to an atmosphere of the test item for a period of four hours. A target
concentration of 5.0 mg/L was used for the exposure. As the mean achieved concentration was 101 % of target and no deaths occurred, no further levels were required.
The temperature and relative humidity inside the exposure chamber were measured by an electronic thermometer/humidity meter (Hanna Instruments Ltd, Beds., UK) located in a vacant port in the animals’ breathing zone of the chamber and recorded every thirty minutes throughout the four-hour exposure period. Oxygen levels within the exposure chamber were measured by an electronic oxygen analyzer (Servomex (UK) Ltd, Crowborough, East Sussex) located in a port in the animals breathing zone during the four-hour exposure period. The test atmosphere was generated to contain at least 19% oxygen. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 5.07 mg/L (achieved)
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- All animals were observed for clinical signs at hourly intervals during exposure, immediately on removal from the restraining tubes at the end of exposure, one hour after termination of exposure and subsequently once daily for fourteen days. Any evidence of overt toxicity was recorded at each observation. Individual body weights were recorded on arrival, prior to treatment on the day of exposure and on Days 1, 3, 7 and 14. At the end of the fourteen day observation period the animals were killed by intravenous overdose of sodium pentobarbitone. All animals were subjected to a full external and internal examination, and any macroscopic abnormalities were recorded. The respiratory tract was subjected to a detailed macroscopic examination for signs of irritancy or local toxicity.
Data evaluations included the relationship, if any, between the animals’ exposure to the test item and the incidence and severity of all abnormalities including behavioral and clinical observations, necropsy findings, body weight changes, mortality and any other toxicological effects. Using the mortality data obtained, an estimate of the acute inhalation median lethal concentration (LC50) of the test item was made. - Statistics:
- Not required.
- Preliminary study:
- Not applicable.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.07 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- No mortalities occured.
- Clinical signs:
- other:
- Body weight:
- All animals exhibited body weight losses on the first day post-exposure. Body weight gains were noted in all animals during the remainder of the recovery period.
- Gross pathology:
- No macroscopic abnormalities were detected amongst animals at necropsy.
- Other findings:
- No other findings reported.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- No deaths occurred in a group of ten rats exposed to a mean achieved atmosphere concentration of 5.07 mg/L for four hours. The acute 4 hr LC50 is therefore considered to be greater than 5.07 mg/L and classification is not required.
- Executive summary:
The acute inhalation toxicity of dipentaerythritol was investigated in 5 male and 5 female RccHAN:WIST rats, according to OECD 403 (2009). The rats were exposed nose-only to a dust atmosphere for four-hours, followed by a 14-day observation period. The mean achieved atmosphere concentration was 5.07 mg/L (nominal 14.4 mg/L). The MMAD was determined to be 1.73 µm with a geometric standard deviation of 3.50, and the inhalable fraction (% <4 µm) was 74.9%. No deaths occurred. Common abnormalities noted during the study included decreased respiratory rate, increased respiratory rate, hunched posture, pilo-erection and wet fur. All animals recovered to appear normal on Day 2 post-exposure. All animals exhibited body weight losses on the first day post-exposure. All animals exhibited body weight gains during the remainder of the recovery period. No macroscopic abnormalities were detected at necropsy. No deaths occurred in a group of ten rats exposed to a mean achieved atmosphere concentration of 5.07 mg/L for four hours; the acute LC50 is therefore considered to be greater than 5.07 mg/L. Classification according to Regulation (EC) No 1272/2008 is not required.
Reference
Table 1: Exposure Chamber Concentration
Atmosphere Concentration |
||
Mean Achieved (mg/L) |
Standard Deviation |
Nominal (mg/L) |
5.07 |
0.17 |
14.4 |
Table 2: Particle Size Distribution
Mean Achieved Atmosphere Concentration (mg/L) |
Mean Mass Median Aerodynamic Diameter (µm) |
Inhalable Fraction (% <4 µm) |
Geometric Standard Deviation |
5.07 |
1.73 |
74.9 |
3.50 |
The chamber flow rate was maintained at 60 L/min providing 120 air changes per hour. The theoretical chamber equilibration time (T99) was 3 minutes* (Silver, 1946).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- > 5.07 mg/L air
- Quality of whole database:
- Modern guideline and GLP-compliant rat study is available for this endpoint
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- other justification
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute oral toxicity
The acute oral toxicity of dipentaerythritol was assessed in a GLP study, according to EU Method B.1 (Allan, 1991).
A group of ten fasted rats (five males and five females) were given a single dose by gavage of the test substance, formulated in distilled water, at a dose level of 2.0 g/kg bodyweight. All animals were killed and examined macroscopically on Day 15, the end of the observation period. There were no deaths. Clinical signs of reaction to treatment were limited to piloerection and abnormal body carriage and recovery was complete by Day 2. Slightly low bodyweight gains were recorded for three males on Day 8; these rats achieved anticipated gains on Day 15. All other rats achieved anticipated bodyweight gains throughout the study. No abnormalities were recorded at the macroscopic examination on Day 15. The acute lethal oral dose to rats of dipentaerythritol was found to be greater than 2.0 g/kg bodyweight.
Acute inhalation toxicity
The acute inhalation toxicity if di-pentaerythritol was assessed in a modern GLP study, according to OECD 403 (Griffiths, 2015). A group of ten rats (five males and five females) were exposed nose-only to a dust atmosphere for four-hours, followed by a 14-day observation period. The mean achieved atmosphere concentration was 5.07 mg/L (nominal 14.4 mg/L). The MMAD was determined to be 1.73 µm with a geometric standard deviation of 3.50, and the inhalable fraction (% <4 µm) was 74.9%. No deaths occurred. Common abnormalities noted during the study included decreased respiratory rate, increased respiratory rate, hunched posture, pilo-erection and wet fur. All animals recovered to appear normal on Day 2 post-exposure. All animals exhibited body weight losses on the first day post-exposure. All animals exhibited body weight gains during the remainder of the recovery period. No macroscopic abnormalities were detected at necropsy. No deaths occurred in a group of ten rats exposed to a mean achieved atmosphere concentration of 5.07 mg/L for four hours; the acute LC50 is therefore considered to be greater than 5.07 mg/L.
Acute dermal toxicity
A waiver is proposed in line with Column 2 of Annex VIII of the REACH regulation. Data relevant to the acute toxicity of the substance by the oral and inhalation routes are available. The substance is of inherently low acute toxicity and dermal absorption is unlikley to be particularly rapid or extensive. Low toxicity by this route can therefore also be reliably be predicted. Additional testing for acute dermal toxicity is not warranted on scientific grounds and for reasons of animal welfare.
Justification for classification or non-classification
The substance is of low acute oral toxicity (LD50 >2000 mg/kg bw) and low acute inhalation toxicity (4 -h LC50 > 5.07 mg/L). No data are available for acute dermal toxicity, however very low toxicity by this route is also predicted. The substance does not therefore require classification for acute toxicity according to the CLP Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.